61
Participants
Start Date
July 31, 2008
Primary Completion Date
August 31, 2011
Study Completion Date
October 31, 2011
Sym001
Each cohort will receive one single dose of Sym001 according the assigned dose level.
Clinical center Vojvodina 3801, Novi Sad
Clinical Center Zemun 3803, Zemun
Clinical Center Nis 3802, Niš
Hospital of the University of Pennsylvania, Site 1002, Philadelphia
Vinnytsya Regional Clinical Hospital, 3902, Vinnytsia
Western Galilee - Nahariya Hospital, 9722, Nahariya
Khmelnytskyi Regional Hospital, 3903, Khmelnytskyi
2085 Henry Tecklenburg Drive, 1001, Charleston
Bnai-Zion Medical Center, 9721, Haifa
Rambam Medical Center, 9723, Haifa
Rabin Medical Center, 9724, Petah Tikva
The Edith Wolfson Medical Center, 9725, Holon
Tel-Aviv Sourasky Medical Center, 9726, Tel Aviv
Gusak Academy of AMS Ukraine, 3905, Donetsk
Cherkassy regional oncology center, 3906, Cherkassy
Saint Petersburg State Institution Of Healthcare, 7001, Saint Petersburg
State Healthcare Institution Tula Regional Clin. Hosp., 7002, Tula
Regional Clinical Hospital na MI Kalinin, 7005, Samara
Apollo Hospital, 9104, Hyderabad
St. John's Medical College Hospital, 9106, Bangalore
MS Ramaiah Memorial Hospital, 9108, Bangalore
Narayana Hrudayalaya Hospitals, 9105, Bangalore
Columbia Asia Referral Hospital-Yeshwanthpur, 9101, Bangalore
Kasturba Medical College Hospital, 9103, Udupi
Aysha Hospital Pvt. Ltd., 9109, Chennai
Regional Clinical Hospital of Nizhny Novgorod, 7003, Nizhny Novgorod
Univ Nebraska Med Ctr. UNMC, 1005, Omaha
Research Site 3203, Bruges
Research Site 3202, Leuven
Research Site 3201, Yvoir
Research Site 4906, 4907, Berlin
Research Site 4902, Cologne
Research Site 4903, Duisburg
Research Site 4905, Essen
Reseach Site 4908, Halle
Research Site 4901, Hanover
Research Site 4904, Regensburg
Research site 4801, Gdansk
Research Site 4806, Krakow
Research Site 4805, Lodz
Instytut Hematologii i Transfuzjologii, 4807, Warsaw
Research Site 4802, 4808, Warsaw
Research Site 4803, Warszava
Research Site 4804, Wroclaw
Brasov Country Hospital, 4002, Brasov
Institutul Clinic Fundeni, 4003, Bucharest
"Prof. Dr. Ion Chiricuta Oncolgy Institute, 4001", Cluj-Napoca
Spitalul Clinic de Urgente Sfantu Spiridon, 4004, Iași
Reseach Site 3403, Barcelona
Hospital Gregorio Maranon, 3405, Madrid
Hospital La Princesa, 3404, Madrid
Research Site 3401, Madrid
Research Site 3402, Valencia
City Hospital #9 Kyiv Clinical Hospital, 3904, Kiev
St. James's University Hospital, 4403, Leeds
Hammersmith Hosptial, 4402, London
University College, 4401, London
Royal Victoria Infirmery, 4404, Newcastle upon Tyne
Singleton Hospital, 4405, Swansea
Collaborators (1)
Swedish Orphan Biovitrum
INDUSTRY
Symphogen A/S
INDUSTRY